Back
Columbia Research Enhanced Value ETF Vs. Summit Therapeutics Industry Stock Comparison
Buy
60
REVS
Columbia Research Enhanced Value ETF
Last Price:
24.93
Seasonality Move:
4.3%
Buy
85
SMMT
Summit Therapeutics
Last Price:
26.20
Seasonality Move:
26.72%
Buy
60
Columbia Research Enhanced Value ETF (REVS)
is a Buy
Is Columbia Research Enhanced Value ETF a Buy, Sell or Hold?
- The current Columbia Research Enhanced Value ETF [REVS] share price is $24.91. The Score for REVS is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- REVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
85
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy, Sell or Hold?
- The current Summit Therapeutics [SMMT] share price is $29.48. The Score for SMMT is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
- SMMT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
REVS Stock Price Chart
What is Columbia Research Enhanced Value ETF's stock price today?
-
The Columbia Research Enhanced Value ETF share price today is $24.91
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $29.48
The current trend is moderately bullish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.
REVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.14 | Buy |
| Relative Strength Index (14 RSI): | 60.71 | Buy |
| Chaikin Money Flow: | 2140 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.18 - 24.92) | Buy |
| Bollinger Bands (100): | (23.13 - 24.37) | Buy |
SMMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.35 | Buy |
| Relative Strength Index (14 RSI): | 80.76 | Buy |
| Chaikin Money Flow: | -10383890 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.54 - 21.66) | Buy |
| Bollinger Bands (100): | (4.24 - 14.54) | Buy |
REVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.57 | Buy |
| 20-day SMA: | 24.69 | Buy |
| 50-day SMA: | 24.22 | Buy |
| 200-day SMA: | 23.03 | Buy |
| 8-day EMA: | 24.66 | Buy |
| 20-day EMA: | 24.57 | Buy |
| 50-day EMA: | 24.25 | Buy |
| 200-day EMA: | 23.11 | Buy |
SMMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.3 | Buy |
| 20-day SMA: | 16.66 | Buy |
| 50-day SMA: | 12.66 | Buy |
| 200-day SMA: | 6.49 | Buy |
| 8-day EMA: | 23.98 | Buy |
| 20-day EMA: | 18.55 | Buy |
| 50-day EMA: | 13.95 | Buy |
| 200-day EMA: | 7.85 | Buy |
Columbia Research Enhanced Value ETF Earnings Growth & REVS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.32 per share, and a decrease next year of $0.03 per share.
Columbia Research Enhanced Value ETF Technical Analysis
| Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Summit Therapeutics Technical Analysis
| Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||